NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.